The past year has marked a turning point for New Approach Methodologies (NAMs) in preclinical drug development. No longer experimental curiosities, these human-relevant approaches have rapidly gained ...
SAN ANTONIO, April 20, 2026 /PRNewswire/ -- Texas Biomedical Research Institute is advancing new tools – known as new approach methodologies (NAMs) – that can accelerate discoveries and drug ...
The New Approach Methodologies (NAMs) initiative aims to replace the use of animal models when testing the safety and efficacy of therapeutics and drugs by promoting the development and adoption of ...
The alternative text for this image may have been generated using AI. Although the FDA’s announcement largely invokes existing legislative authority 3, it nonetheless marks a significant acceleration ...
TUCSON, Ariz., and AMSTERDAM, May 19, 2026 — Critical Path Institute® (C-Path) today announced the launch of the New Approach Methodologies Developer Coalition (NAMs-DC), a precompetitive, ...
As regulatory authorities accelerate the use of New Approach Methodologies (NAMs), the drug discovery landscape is changing dramatically. This webinar explores how NAMs, immunology-driven platforms, ...
The International Society for Stem Cell Research (ISSCR) Consortium on Advanced Stem Cell-Based Models in Drug Discovery and Development has submitted comments to the U.S. Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results